30 related articles for article (PubMed ID: 38683513)
1. Macroscopic tumor dimension, sentinel lymph node outcome, and survival analysis among cutaneous melanoma.
Asato MA; Moraes-Neto FA; Moraes MPT; Ocanha-Xavier JP; Alencar Marques ME; Xavier-Junior JCC
Int J Dermatol; 2024 Jun; 63(6):765-772. PubMed ID: 38217520
[TBL] [Abstract][Full Text] [Related]
2. Secondary Sentinel Lymph Node: An Original Staging Approach in Cutaneous Melanoma.
Pina LN; Graneros LE; Montesinos MF; Eiben GA; Barrios Jirsa SD; Avagnina MA; Paradeda ME; Sinagra DL; Montesinos MR
J Cutan Med Surg; 2024; 28(3):287-289. PubMed ID: 38353148
[No Abstract] [Full Text] [Related]
3. Corrigendum to investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey Journal of Plastic, Reconstructive & Aesthetic Surgery [Volume 91, April 2024, Pages 167-172].
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 May; 94():210. PubMed ID: 38820690
[No Abstract] [Full Text] [Related]
4. Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Svedman FC; Pillas D; Taylor A; Kaur M; Linder R; Hansson J
Clin Epidemiol; 2016; 8():109-22. PubMed ID: 27307765
[TBL] [Abstract][Full Text] [Related]
5. Investigation of prognostic factors for non-sentinel lymph node metastasis in patients undergoing sentinel lymph node biopsy for cutaneous malignant melanoma: Experience from a reference centre in Turkey.
Yalcin CE; Melenkis S; Demir L; Okur FT; Sagir MS; Ercan A
J Plast Reconstr Aesthet Surg; 2024 Apr; 91():167-172. PubMed ID: 38417393
[TBL] [Abstract][Full Text] [Related]
6. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
[TBL] [Abstract][Full Text] [Related]
7. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.
Lee DY; Lau BJ; Huynh KT; Flaherty DC; Lee JH; Stern SL; O'Day SJ; Foshag LJ; Faries MB
J Am Coll Surg; 2016 Jul; 223(1):9-18. PubMed ID: 27236435
[TBL] [Abstract][Full Text] [Related]
8. Current management of patients with cutaneous melanoma with a positive sentinel lymph node.
Quildrian SD; Nardi WS; Scasso V; Novas C; Bella Quero L; Silva C
Medicina (B Aires); 2023; 83(3):376-383. PubMed ID: 37379534
[TBL] [Abstract][Full Text] [Related]
9. Complete lymph node dissection or observation in melanoma patients with multiple positive sentinel lymph nodes: A single-center retrospective analysis.
Persa OD; Knuever J; Mauch C; Schlaak M
J Dermatol; 2018 Oct; 45(10):1191-1194. PubMed ID: 30095864
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis.
Broman KK; Hughes TM; Dossett LA; Sun J; Carr MJ; Kirichenko DA; Sharma A; Bartlett EK; Nijhuis AA; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma J; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras RM; Teras J; Farrow NE; Beasley GM; Hui JY; Been L; Kruijff S; Boulware D; Sarnaik AA; Sondak VK; Zager JS;
J Am Coll Surg; 2021 Apr; 232(4):424-431. PubMed ID: 33316427
[TBL] [Abstract][Full Text] [Related]
11. Recurrence factors in patients with cutaneous melanoma and positive sentinel lymph node treated in a single reference unit in Buenos Aires.
Nardi WS; Toffolo Pasquini M; Tomé F; Vigovich F; Cora MF; Quildrian SD
Medicina (B Aires); 2024; 84(2):279-288. PubMed ID: 38683513
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma.
Kyrgidis A; Tzellos T; Mocellin S; Apalla Z; Lallas A; Pilati P; Stratigos A
Cochrane Database Syst Rev; 2015 May; 2015(5):CD010307. PubMed ID: 25978975
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]